// App-Quantinova.ai

583 : Evaluation of EphA2 as a therapeutic target for redirected T-cell killing by DART bispecific molecules

Researchers

Presenter

  • Claudia B. Fieger

Principal Investigators

  • Kalpana Shah

  • Gurunadh Chichili

  • Jonathan Li

  • Thomas Son

  • Jeffrey Hooley

  • Francine Chen

  • Sergey Gorlatov

  • Steve Burke

  • Valentina Ciccarone

  • Ralph Alderson

  • Deryk Loo

  • Syd Johnson

  • Ezio Bonvini

  • Paul Moore

Medical Centers

  • MacroGenics, Inc, South San Francisco, CA

  • MacroGenics, Inc., Rockville, MD

Locations

  • United States

Companies

  • MacroGenics, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved